Telormedix Raises $19 Million
Telormedix SA, a Swiss developer of immunotherapeutics, has raised around CHF 21 million ($19m) in Series A funding. Aravis Ventures led the round, and was joined by Proquest Investments, BSI SA, Nextech Venture and Generali Insurance Group
30 September 2008•4 mins read
